These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 9457059

  • 21. Bcl-x protects primary B cells against Fas-mediated apoptosis.
    Schneider TJ, Grillot D, Foote LC, Núñez GE, Rothstein TL.
    J Immunol; 1997 Nov 15; 159(10):4834-9. PubMed ID: 9366408
    [Abstract] [Full Text] [Related]

  • 22. Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cells.
    Aicher A, Shu GL, Magaletti D, Mulvania T, Pezzutto A, Craxton A, Clark EA.
    J Immunol; 1999 Dec 01; 163(11):5786-95. PubMed ID: 10570261
    [Abstract] [Full Text] [Related]

  • 23. CD40 and adenosine A2 receptor agonist-cyclic adenosine monophosphate rescue B-cell antigen receptor-induced apoptosis through independent pathways and converge to prevent caspase activation.
    Sakata N, Kawasome H, Terada N, Johnson GL, Gelfand EW.
    J Allergy Clin Immunol; 2000 Mar 01; 105(3):522-31. PubMed ID: 10719303
    [Abstract] [Full Text] [Related]

  • 24. Bcl-xL rescues WEHI 231 B lymphocytes from oxidant-mediated death following diverse apoptotic stimuli.
    Fang W, Rivard JJ, Ganser JA, LeBien TW, Nath KA, Mueller DL, Behrens TW.
    J Immunol; 1995 Jul 01; 155(1):66-75. PubMed ID: 7602123
    [Abstract] [Full Text] [Related]

  • 25. Expression of bcl-x during mouse B cell differentiation and following activation by various stimuli.
    Choi MS, Holmann M, Atkins CJ, Klaus GG.
    Eur J Immunol; 1996 Mar 01; 26(3):676-82. PubMed ID: 8605937
    [Abstract] [Full Text] [Related]

  • 26. Dominant signals leading to inhibitor kappaB protein degradation mediate CD40 ligand rescue of WEHI 231 immature B cells from receptor-mediated apoptosis.
    Schauer SL, Bellas RE, Sonenshein GE.
    J Immunol; 1998 May 01; 160(9):4398-405. PubMed ID: 9574544
    [Abstract] [Full Text] [Related]

  • 27. Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa B, and p53.
    Han SS, Chung ST, Robertson DA, Ranjan D, Bondada S.
    Clin Immunol; 1999 Nov 01; 93(2):152-61. PubMed ID: 10527691
    [Abstract] [Full Text] [Related]

  • 28. Strength of signal through BCR determines the fate of cycling B cells by regulating the expression of the Bcl-2 family of survival proteins.
    Pittner BT, Snow EC.
    Cell Immunol; 1998 May 25; 186(1):55-62. PubMed ID: 9637765
    [Abstract] [Full Text] [Related]

  • 29. Differential induction of apoptosis and MAP kinase signaling by mitochondrial toxicants in drug-sensitive compared to drug-resistant B-lineage lymphoid cell lines.
    O'Brien KA, Muscarella DE, Bloom SE.
    Toxicol Appl Pharmacol; 2001 Aug 01; 174(3):245-56. PubMed ID: 11485385
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.
    Jazirehi AR, Vega MI, Chatterjee D, Goodglick L, Bonavida B.
    Cancer Res; 2004 Oct 01; 64(19):7117-26. PubMed ID: 15466208
    [Abstract] [Full Text] [Related]

  • 31. Repression of apoptosis in human B-lymphoma cells by CD40-ligand and Bcl-2: relationship to the cell-cycle and role of the retinoblastoma protein.
    Wang H, Grand RJ, Milner AE, Armitage RJ, Gordon J, Gregory CD.
    Oncogene; 1996 Jul 18; 13(2):373-9. PubMed ID: 8710376
    [Abstract] [Full Text] [Related]

  • 32. Activation of the cAMP signaling pathway increases apoptosis in human B-precursor cells and is associated with downregulation of Mcl-1 expression.
    Myklebust JH, Josefsen D, Blomhoff HK, Levy FO, Naderi S, Reed JC, Smeland EB.
    J Cell Physiol; 1999 Jul 18; 180(1):71-80. PubMed ID: 10362019
    [Abstract] [Full Text] [Related]

  • 33. Bcl-XL induction during terminal differentiation of friend erythroleukaemia cells correlates with delay of apoptosis and loss of proliferative capacity but not with haemoglobinization.
    Hafid-Medheb K, Poindessous-Jazat V, Augery-Bourget Y, Hanania N, Robert-Lézénès J.
    Cell Death Differ; 1999 Feb 18; 6(2):166-74. PubMed ID: 10200563
    [Abstract] [Full Text] [Related]

  • 34. Role of cell signaling in B[a]P-induced apoptosis: characterization of unspecific effects of cell signaling inhibitors and apoptotic effects of B[a]P metabolites.
    Solhaug A, Øvrebø S, Mollerup S, Låg M, Schwarze PE, Nesnow S, Holme JA.
    Chem Biol Interact; 2005 Jan 15; 151(2):101-19. PubMed ID: 15698582
    [Abstract] [Full Text] [Related]

  • 35. Overexpression of BCL-X(L) underlies the molecular basis for resistance to staurosporine-induced apoptosis in PC-3 cells.
    Li X, Marani M, Mannucci R, Kinsey B, Andriani F, Nicoletti I, Denner L, Marcelli M.
    Cancer Res; 2001 Feb 15; 61(4):1699-706. PubMed ID: 11245486
    [Abstract] [Full Text] [Related]

  • 36. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
    de Totero D, Tazzari PL, Capaia M, Montera MP, Clavio M, Balleari E, Foa R, Gobbi M.
    Haematologica; 2003 Feb 15; 88(2):148-58. PubMed ID: 12604404
    [Abstract] [Full Text] [Related]

  • 37. Follicular dendritic cells protect malignant B cells from apoptosis induced by anti-Fas and antineoplastic agents.
    Schwarz YX, Yang My, Qin D, Wu J, Jarvis WD, Grant S, Burton GF, Szakal AK, Tew JG.
    J Immunol; 1999 Dec 15; 163(12):6442-7. PubMed ID: 10586034
    [Abstract] [Full Text] [Related]

  • 38. Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis.
    Hinz S, Trauzold A, Boenicke L, Sandberg C, Beckmann S, Bayer E, Walczak H, Kalthoff H, Ungefroren H.
    Oncogene; 2000 Nov 16; 19(48):5477-86. PubMed ID: 11114725
    [Abstract] [Full Text] [Related]

  • 39. Bcl-2 down modulation in WEHI-3B/CTRES cells resistant to Cholera Toxin (CT)-induced apoptosis.
    Pessina A, Croera C, Savalli N, Bonomi A, Cavicchini L, Turlizzi E, Guizzardi F, Guido L, Daprai L, Neri MG.
    Cell Res; 2006 Mar 16; 16(3):306-12. PubMed ID: 16541129
    [Abstract] [Full Text] [Related]

  • 40. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
    Ravi R, Bedi A.
    Cancer Res; 2002 Aug 01; 62(15):4180-5. PubMed ID: 12154014
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.